Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 1/20 | 0.32 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.32 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.31 |
| ▸ | TSPO | P30536 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15762318 | 1.00 | PLA2G2A (0.32) | PLA2G2APLA2G4AHSP90AA1HSP90AB1TSPO | |
| SCHEMBL30570861 | 1.00 | PLA2G2A (0.32) | PLA2G2APLA2G4AHSP90AA1HSP90AB1TSPO | |
| SCHEMBL10040806 | 0.99 | PLA2G2A (0.31) | PLA2G2APLA2G4AHSP90AA1HSP90AB1TSPO | |
| SCHEMBL15762310 | 0.99 | PLA2G2A (0.31) | PLA2G2APLA2G4AHSP90AA1HSP90AB1TSPO | |
| SCHEMBL9916431 | 0.97 | KDM4E (0.32) | HSP90AA1HSP90AB1TSPO | |
| SCHEMBL9916878 | 0.97 | KDM4E (0.32) | HSP90AA1HSP90AB1TSPO | |
| SCHEMBL9916873 | 0.97 | KDM4E (0.32) | HSP90AA1HSP90AB1TSPO | |
| SCHEMBL9916875 | 0.96 | KDM4E (0.32) | HSP90AA1HSP90AB1TSPO | |
| SCHEMBL9916896 | 0.96 | KDM4E (0.32) | HSP90AA1HSP90AB1TSPO | |
| SCHEMBL9916882 | 0.96 | KDM4E (0.32) | HSP90AA1HSP90AB1TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9478753-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same, and display device including the light emitting diode | CHEIL INDUSTRIES, INC. (KR) | 2016-10-25 | — | — | US | disclosed |
| US-9478753-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same, and display device including the light emitting diode | CHEIL INDUSTRIES, INC. (KR) | 2016-10-25 | — | — | US | disclosed |
| US-20140070199-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | JUNG SUNG-HYUN (KR) | 2014-03-13 | — | — | US | disclosed |
| US-20140070199-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | JUNG SUNG-HYUN (KR) | 2014-03-13 | — | — | US | disclosed |
| US-20120043531-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-02-23 | — | — | US | disclosed |
| US-20120043531-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120043531-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE LIGHT EMITTING DIODE | AOX1, OR10J3, OCIAD1 | PLA2G2A 4559/4885PLA2G4A 4360/4885HSP90AA1 4499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.